Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-09-13

Clinical Trial Update: Enoxaparin Metabolism in Reconstructive Surgery Patients [Phase 2]

View source ↗

Summary

A Phase 2 trial update on enoxaparin metabolism in reconstructive surgery patients, with completed status and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Enoxaparin (enoxaparin sodium)

Snippet

Sponsor: University of Utah | Conditions: Venous Thromboembolism, Deep Venous Thrombosis | Phase 2 | Status: COMPLETED | Results posted: 2017-09-13